Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Posted On: 2021-03-06 04:25:29 (Time Zone: Arizona, USA)


Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India's recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.

Government of India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical 'Key Starting Materials (KSMs) / Drug Intermediates / Active Pharmaceutical Ingredients (APIs)' in the country. The tenure of the scheme is from FY21 to FY30.

The applications under four different Target Segments were invited with 30 November 2020 as the last date. In total, 215 applications were received for the 41 products spread across the 4 Target Segments.

Aarti Speciality Chemicals Limited, a wholly-owned subsidiary of Aarti Drugs Limited received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum under Target Segment III (Key Chemical Synthesis Based KSMs/Drug Intermediates). The rate incentive will be 10 per cent of sales value per annum for a period of 6 years - FY23 to FY28.

Commenting on the Government's approval Mr. Adhish Patil, Chief Financial Officer - Aarti Drugs Limited said: "We welcome the government's approval to our application under PLI scheme to manufacture 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum. This is a very positive development for us, as it will help the company to diversify its product portfolio, increase the top-line and enhance the profitability & margin profile of the company.

Backed by a strong Balance Sheet, and robust free cash flow generation, the committed capex will be funded through a mix of debt and internal accruals. We are expecting the capex for this project to be spread over a period of 18 months. This will further reduce our dependence on imports.

As a strategy, we have always focused on import substitution and will continue to pursue various opportunities. We remain committed to "Atmanirbhar Bharat" vision of the Government."

Shares of AARTI DRUGS LTD. was last trading in BSE at Rs.667.1 as compared to the previous close of Rs. 691.05. The total number of shares traded during the day was 18902 in over 1169 trades.

The stock hit an intraday high of Rs. 696.55 and intraday low of 660.95. The net turnover during the day was Rs. 12711803.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

TCS Named a Leader in the 2021 Gartner Magic Quadrant for Managed Workplace Services, Asia Pacific

Shri Bajrang Alliance Limited's Agro Division now certified under Food Safety Management System

5Paisa Capital Ltd Q4FY21 consolidated net profit surges to Rs. 5.85 crore

Accelya Solutions India Ltd board to consider Q3FY21 results on April 30, 2021

Van Heusen launches new sub-brand 'Denim Labs'

Shriram City Union Finance Ltd board to approve final dividend, FY21 results on April 30, 2021

Larsen & Toubro Infotech Ltd board to conider Q4, FY21 results, dividend on May 4, 2021

Cipla Ltd board to consider Q4, FY21 results, dividend on May 14, 2021

Tata Steel Long Products Ltd Board approves dividend of Rs. 5

Swaraj Engines Limited announces Q4FY21 results

AstraZeneca Pharma India Limited launches Fasenra™

Hero MotoCorp to undertake temporary suspension of manufacturing operations as precautionary measure

Salasar Techno Engineering Ltd receives orders worth Rs. 47.70 crore

Supreme Petrochem Ltd Board to consider FY21 results & Dividend on April 30, 2021

IRDAI imposes penalty of Rs. 25 lacs on SBI General Insurance Company Limited

Tata Steel Long Products Ltd Q4FY21 consolidated PAT soars to Rs. 339.86 crore

Network18 Media & Investments Ltd reports Rs. 39.13 crore consolidated PAT in Q4FY21

Quick Heal Technologies Ltd fixes May 3, 2021 as record date for Buy Back

TV18 Broadcast Ltd reports Q4FY21 consolidated PAT of Rs. 165.88 crore

Swaraj Engines Ltd Board approves dividend of Rs. 50, special dividend of Rs. 19

Blue Dart Express Ltd board to consider Q4, FY21 results, dividend on May 5, 2021

Swaraj Engines Ltd Q4FY21 PAT surges to Rs. 32.56 crore

Narendra Investments Delhi Ltd Q4FY21 PAT up at Rs. 0.35 crore

Nestle India Ltd reports jump in net profit to Rs. 602.25 crore in Q1CY21

Central Bank of India board approves issue of shares at Rs. 17.11

Saregama strikes a long term music deal with Sanjay Leela Bhansali

Nestle India Ltd board declares interim dividend of Rs. 25 for CY2021

TCI Industries Limited approves issue of 107602 NCRPS

Alembic Pharmaceuticals Ltd board to consider Q4, FY21 results on March 31, 2021

GatewayRail's inaugural 'Maersk Automotive Express Service' flagged off by Denmark's Ambassador to India

Renowned author Gurcharan Das unveils Emkay Investment Manager's book on 'E-Qual' framework

HCG Cancer Hospital Bengaluru successfully operates on a patient with 'Congenital Hemophilia'

Suprajit Engineering initiates a nation-wide campaign against Counterfeit Products

Adani Enterprises Ltd forms Mundra Petrochem Ltd

Morganite Crucible (India) Limited board to recommend dividend, approve Q4, FY21 results on May 18, 2021

Dhanlaxmi Bank Limited shifts corporate office

Hindustan Zinc Ltd board to consider Q4, FY21 results on April 27, 2021

Yes Bank Ltd board to consider FY21 results on April 30, 2021

Ramco Global Payroll Now Available on Oracle Cloud Marketplace

TCS ADD Safety Wins Award for Using AI to Re-Imagine Pharmacovigilance

LTI Recognized Among the Top Performers in Nordic Region

Rashmika Mandanna Just Can't Get Enough of the new McSpicy Fried Chicken in the latest campaign launched by McDonald's

Mr. Satyam Bansal to be engaged as an Advisor for Deccan Health Care Limited

Sterlite Technologies Ltd board to recommend final dividend, consider FY21 results on April 29, 2021

Shree Digvijay Cement Company Ltd Board to consider Dividend for FY21

Hero MotoCorp adopts Aravali Biodiversity Park in Gurugram

IIFL Wealth Management Ltd board to consider Q4, FY21 results on May 18, 2021

Automotive Stampings and Assemblies Ltd board to approve Q4FY21, FY2021 results on April 26, 2021

Anmol India Ltd board to consider allotment of 10 lakh shares on April 23, 2021

CRISIL Limited announces Unaudited financial results for the first quarter ended March 31, 2021


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020